RWML
AMRX icon

RAFFA WEALTH MANAGEMENT, LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87 Buy
5
+4
+400% +$55 ﹤0.01% 1414
2026
Q1 		$12 Buy
+1
New +$13 ﹤0.01% 1501

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's AMRX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Amneal Pharmaceuticals (AMRX) stake by 400% in Q2 2026, buying an estimated $55 and bringing the position to 5 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 5 shares of Amneal Pharmaceuticals worth $87 as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 4 Amneal Pharmaceuticals shares in Q2 2026, an estimated $55.
  • Amneal Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1414 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.